Your browser doesn't support javascript.
loading
Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.
van Vliembergen, Eline N M; Eijkelenkamp, Hidde; Valk, Gerlof D; Vriens, Menno R; Meijer, Gert J; Intven, Martijn P W; de Laat, Joanne M.
Affiliation
  • van Vliembergen ENM; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Eijkelenkamp H; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Valk GD; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, Netherlands.
  • Vriens MR; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Meijer GJ; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Intven MPW; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, Netherlands.
  • de Laat JM; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, Netherlands.
Front Endocrinol (Lausanne) ; 14: 994370, 2023.
Article in En | MEDLINE | ID: mdl-37305036
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors / Neuroectodermal Tumors, Primitive / Multiple Endocrine Neoplasia Type 1 / Drug-Related Side Effects and Adverse Reactions Type of study: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Aspects: Patient_preference Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors / Neuroectodermal Tumors, Primitive / Multiple Endocrine Neoplasia Type 1 / Drug-Related Side Effects and Adverse Reactions Type of study: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Aspects: Patient_preference Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: